Pricing Log in Create free account

Contineum Therapeutics, Inc. (CTNM) vs Zura Bio Limited (ZURA)

Contineum Therapeutics, Inc. and Zura Bio Limited are both Biotechnology companies. Contineum Therapeutics, Inc. and Zura Bio Limited are of similar size ($358.3M and $345.9M). Across the 9 metrics below, Contineum Therapeutics, Inc. leads on 7 and Zura Bio Limited on 2.

Valuation

Metric CTNM ZURA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.47 2.95 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (18.76%) (27.30%) (32.88%)
Free cash flow yield (14.44%) (16.52%) (23.13%)

Profitability

Metric CTNM ZURA Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (29.80%) (85.05%) (51.96%)
Return on assets (28.34%) (72.21%) (46.06%)
Return on invested capital (4,845.62%) 0.00% 0.00%

Growth

Metric CTNM ZURA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 0.46% (76.67%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTNM ZURA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.11 11.29 4.97
Net debt to EBITDA 3.88 1.45 1.01

Dividend

Metric CTNM ZURA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTNM ZURA Biotechnology median
Market cap 345.93m 358.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack